newdrugapprovals.org
Karyopharm Announces Initiation of Phase 2 Study of Selinexor (KPT-330) an orphan drug
Selinexor (KPT-330) 1393477-72-9 Karyopharm Therapeutics, Inc. WO2011109799A1 WO2013019548A1 synthesis at C17-H11-F6-N7-O 443.3099 Synonyms (Z)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H…